Transforming drug development with AI for faster and safer repurposing
Schedule a Demo →AICURA’s drug repurposing platform identifies promising new uses for existing drugs, reducing time to market and lowering R&D costs. Our platform integrates real-world medical data, preclinical insights, and advanced AI to create a streamlined pathway from discovery to clinical validation.
We integrate multimodal data to build Knowledge Graphs mapping complex relationships across drug targets, pathways, and diseases.
✓ 10+ open datasets containing drug, disease (including rare diseases), phenotype, proteins, genetics, and adverse events interactions
✓ Proprietary clinical and pre-clinical datasets
Our AI System builds connections between existing drugs and potential new indications by:
✓ Mapping molecular pathways, drug-target interactions, and disease profiles
✓ Identifying, predicting, and validating novel targets, biomarkers, and mechanisms of action (MoA)
✓ Ranking promising candidates based on biological plausibility and potential therapeutic impact
With advanced AI modeling, we predict the effectiveness of repurposed drugs:
✓ Predictive algorithms assess treatment outcomes and safety profiles for each new indication
✓ Risk assessment tools de-risk clinical trials by using historical and real-world patient data
Our platform enhances clinical trial design for repurposed drugs by validating patient selection criteria and leveraging data-driven insights. Through comprehensive analysis, we identify optimal candidates for each repurposed drug while streamlining trial processes and optimizing study parameters to maximize the likelihood of regulatory approval.
AICURA's comprehensive AI platform is transforming traditional drug development by combining advanced data integration, intelligent disease mapping, and predictive modeling. Through our innovative approach to drug repurposing, we streamline the path from discovery to validation while significantly reducing development time and costs. Our platform empowers researchers and pharmaceutical companies to make data-driven decisions, optimize clinical trials, and ultimately bring life-changing treatments to patients faster and more efficiently than ever before.
AICURA provides exclusive access to multimodal data and advanced AI Systems designed to accelerate and de-risk clinical programs. All of this is delivered within a secure and compliant federated infrastructure that prioritizes data integrity and patient privacy.
✓AI-ready multimodal data
✓ Easy-to-implement AI Systems
✓ Federated and secure access